People: Cantel Medical Corp (CMN)
CMN on New York Consolidated
33.89USD
23 May 2013
33.89USD
23 May 2013
Price Change (% chg)
$-0.03 (-0.09%)
$-0.03 (-0.09%)
Prev Close
$33.92
$33.92
Open
$33.69
$33.69
Day's High
$34.07
$34.07
Day's Low
$33.46
$33.46
Volume
25,026
25,026
Avg. Vol
95,698
95,698
52-wk High
$35.96
$35.96
52-wk Low
$21.01
$21.01
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Charles Diker |
78 | 1986 | Chairman of the Board |
Andrew Krakauer |
57 | 2009 | President, Chief Executive Officer, Director |
Craig Sheldon |
50 | 2008 | Chief Financial Officer, Senior Vice President, Treasurer |
Jorgen Hansen |
45 | 2012 | Chief Operating Officer, Executive Vice President |
Eric Nodiff |
55 | 2009 | Senior Vice President, General Counsel, Corporate Secretary |
Steven Anaya |
42 | 2003 | Vice President, Controller |
Mark Diker |
46 | 2007 | Director |
Alan Batkin |
68 | 2004 | Presiding Independent Director |
Ann Berman |
60 | 2011 | Independent Director |
Joseph Cohen |
75 | 2000 | Independent Director |
George Fotiades |
59 | 2008 | Independent Director |
Alan Hirschfield |
77 | 2009 | Independent Director |
Peter Pronovost |
47 | 2010 | Independent Director |
Bruce Slovin |
76 | 1986 | Independent Director |
Biographies
| Name | Description |
|---|---|
Charles Diker |
Mr. Charles M. Diker is Chairman of the Board of Cantel Medical Corp. Mr. Diker has served as a managing partner of Diker Management LLC, a registered investment adviser, for more than the past five years. He is also a director of Loews Corporation (NYSE), a holding company whose subsidiaries include a commercial property-casualty insurer; an offshore drilling company; natural gas exploration, production and pipeline operation companies; and a luxury lodging company. |
Andrew Krakauer |
Mr. Andrew A. Krakauer is President, Chief Executive Officer, Director of Cantel Medical Corp. From August 2004 through April 2008 he served as Executive Vice President and Chief Operating Officer. For more than five years prior thereto, he served as President of the Ohmeda Medical Division of Instrumentarium / GE Healthcare. Mr. Krakauer's detailed knowledge of the Company's business and operations, his service as a senior executive and his experience as President of Medivators Inc., past Chief Operating Officer of the Company, and interim President of the Company's water purification operations qualify him to serve on the Board. |
Craig Sheldon |
Mr. Craig A. Sheldon is Chief Financial Officer, Senior Vice President, Treasurer of Cantel Medical Corp. Mr. Sheldon, who has been employed in executive capacities since November 1994, has served as Senior Vice President and Chief Financial Officer since November 2002. In March 2008, Mr. Sheldon was also appointed Treasurer. Mr. Sheldon is a certified public accountant (CPA) and a chartered global management accountant (CGMA). |
Jorgen Hansen |
Mr. Jorgen B. Hansen is Executive Vice President and Chief Operating Officer of Cantel Medical Corp. He has been in global positions with increasing responsibility within the healthcare and medical devices industry for over fifteen years. Most recently, he was Senior Vice President, Global Marketing, Business Development, Science and Innovation for ConvaTec Corp. Prior to that, he held leadership roles in Asia and Europe ranging from General Manager, Division head and Senior Vice President of Global Operations for Coloplast A/S. |
Eric Nodiff |
Mr. Eric W. Nodiff is Senior Vice President, General Counsel, Corporate Secretary of Cantel Medical Corp. Mr. Nodiff has served as Senior Vice President and General Counsel since January 2005. In January 2009, Mr. Nodiff was also appointed Secretary. |
Steven Anaya |
Mr. Steven C. Anaya is Vice President, Controller of Cantel Medical Corp. Mr. Anaya, who has been employed since March 2002, has served as Vice President since November 2003 and Controller since November 2002. Prior thereto, he served as Assistant Controller. Mr. Anaya is a certified public accountant (CPA) and a chartered global management accountant (CGMA). |
Mark Diker |
Mr. Mark N. Diker is Director of Cantel Medical Corporation. He is co-managing partner of Diker Management LLC, a registered investment adviser, for more than the past five years. |
Alan Batkin |
Mr. Alan R. Batkin is Presiding Independent Director of Cantel Medical Corporation. He is Vice Chairman, Eton Park Capital Management, L.P., an investment firm, since February 2007. For more than five years prior thereto, Mr. Batkin served as Vice Chairman of Kissinger Associates, Inc., a geopolitical consulting firm that advises multi-national companies. He is also a director of Hasbro, Inc. (NYSE), a toy and game company and Omnicom Group, Inc. (NYSE), a global marketing and corporate communications company. Mr. Batkin also served as a director of Overseas Shipholding Group, Inc. (NYSE), a company that operates oceangoing bulk cargo vessels, and Diamond Offshore Drilling, Inc. (NYSE), a deepwater drilling contractor during the last five years. |
Ann Berman |
Ms. Ann E. Berman is Independent Director of Cantel Medical Corp. From April 2006 through June 2009, Ms. Berman served as senior advisor to the president of Harvard University. From 2002 through April 2006 she served as Vice President of Finance and Chief Financial Officer of Harvard University. Ms. Berman is a certified public accountant, and is also a director of Loews Corporation (NYSE), a holding company whose subsidiaries include a commercial property-casualty insurer; an offshore drilling company; natural gas exploration, production and pipeline operation companies; and a luxury lodging company; and Eaton Vance Corporation, an investment manager. |
Joseph Cohen |
Mr. Joseph M. Cohen is Independent Director of Cantel Medical Corporation. He is Chairman of JM Cohen & Co., investment group, for more than the past five years. Mr. Cohen's career-long experience with matters of business has assisted the Board's consideration of management issues and strategic initiatives, many of which involve complex financial arrangements. This experience qualifies Mr. Cohen to serve on the Board. |
George Fotiades |
Mr. George L. Fotiades is Independent Director of Cantel Medical Corporation. He is Operating Partner—Chairman, Healthcare investments at Diamond Castle Holdings, LLC, a private equity firm, since April 2007. For more than five years prior thereto, Mr. Fotiades served as President and COO of Cardinal Health, Inc., provider of healthcare products and services. Previously, he served as President and CEO of Cardinal's Pharmaceutical Technologies and Services segment, which was subsequently acquired by Blackstone and renamed Catalent Pharma Solutions. Mr. Fotiades also served as Catalent's Chairman from 2007 until 2010. He is also a director of Prologis, Inc. (NYSE), owner, operator and developer of industrial real estate, and Aptargroup Inc. (NYSE), in the global dispensing systems industry. Mr. Fotiades has served as Vice Chairman of the Board of Cantel and a non-executive member of the Office of the Chairman since April 2008. |
Alan Hirschfield |
Mr. Alan J. Hirschfield is Independent Director of Cantel Medical Corporation. He is Private investor and consultant for more than the past five years. Mr. Hirschfield is also a director of Carmike Cinemas, Inc. (NASDAQ), a national theater chain, and Leucadia National Corp. (NYSE), a holding company engaged in various operating and investing activities. He served as Vice Chairman of the Board of Cantel from 1988 until March 2009. Mr. Hirschfield has managerial experience in the media and entertainment sector, as well as in investment banking and real estate. |
Peter Pronovost |
Dr. Peter J. Pronovost, M.D., Ph.D., is Independent Director of Cantel Medical Corp. He is Johns Hopkins University School of Medicine (Departments of Anesthesiology and Critical Care Medicine), in the Bloomberg School of Public Health (Department of Health Policy and Management) and in the School of Nursing for more than the past five years. In addition, Dr. Pronovost serves as a practicing anesthesiologist and critical care physician, researcher, lecturer and international patient safety leader. He is also the Director of the Armstrong Institute for Patient Safety and Quality and is Johns Hopkins Medicine's senior vice president for patient safety and quality. Dr. Pronovost is a lecturer and author in the fields of patient safety, ICU care, quality health care, evidence-based medicine, and the measurement and evaluation of safety efforts. His research is centered on improving the quality of care delivered in the intensive care unit and operating suite and improving patient safety in these and other clinical areas. |
Bruce Slovin |
Mr. Bruce Slovin is Independent Director of Cantel Medical Corporation. He is President, 1 Eleven Associates, LLC, a private investment firm, for more than the past five years. Mr. Slovin is also Chairman of MWest Holdings, LLC, a diversified commercial and residential real estate firm since 1991. He is also a director of SIGA Technologies, Inc. (NASDAQ), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Charles Diker |
512,679 |
Andrew Krakauer |
1,863,100 |
Craig Sheldon |
881,678 |
Jorgen Hansen |
-- |
Eric Nodiff |
888,177 |
Steven Anaya |
518,194 |
Mark Diker |
-- |
Alan Batkin |
-- |
Ann Berman |
-- |
Joseph Cohen |
-- |
George Fotiades |
-- |
Alan Hirschfield |
-- |
Peter Pronovost |
-- |
Bruce Slovin |
-- |
As Of 30 Jul 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Charles Diker |
492,900 | 4,729,937 |
Andrew Krakauer |
116,250 | 693,465 |
Craig Sheldon |
59,075 | 885,849 |
Jorgen Hansen |
0 | 0 |
Eric Nodiff |
82,000 | 126,573 |
Steven Anaya |
0 | 0 |
Mark Diker |
0 | 0 |
Alan Batkin |
0 | 0 |
Ann Berman |
0 | 0 |
Joseph Cohen |
0 | 0 |
George Fotiades |
0 | 0 |
Alan Hirschfield |
0 | 0 |
Peter Pronovost |
0 | 0 |
Bruce Slovin |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
FOTIADES GEORGE L |
4,982 | $31.61 |
FOTIADES GEORGE L |
22,500 | $7.00 |
HIRSCHFIELD ALAN J |
1,125 | $6.36 |
COHEN JOSEPH M |
1,125 | $6.36 |
YELLIN SETH M |
680 | $29.78 |
SLOVIN BRUCE |
1,125 | $6.36 |
DIKER MARK N |
241 | $29.66 |
DIKER MARK N |
1,125 | $6.36 |
COHEN JOSEPH M |
1,125 | $7.72 |
SLOVIN BRUCE |
1,125 | $7.72 |
DIKER MARK N |
1,125 | $7.72 |
DIKER MARK N |
276 | $31.46 |
NODIFF ERIC W |
3,000 | $31.51 |
KRAKAUER ANDREW A |
17,376 | $29.30 |
KRAKAUER ANDREW A |
3,900 | $0.00 |
BATKIN ALAN R |
1,125 | $6.40 |
BATKIN ALAN R |
1,514 | $29.07 |
BATKIN ALAN R |
1,125 | $7.72 |
BATKIN ALAN R |
1,125 | $6.36 |
DIKER CHARLES M |
9,000 | $29.17 |
BATKIN ALAN R |
1,125 | $6.22 |
BATKIN ALAN R |
2,250 | $6.22 |
DIKER CHARLES M |
9,115 | $29.05 |
DIKER CHARLES M |
870 | $0.00 |
DIKER CHARLES M |
5,000 | $0.00 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
